Skills-based medication training program for patients with schizophrenic disorders: a rater-blind randomized controlled trial
Authors Schirmer U, Steinert T, Flammer E, Borbé R
Received 10 October 2014
Accepted for publication 13 December 2014
Published 1 April 2015 Volume 2015:9 Pages 541—549
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Johnny Chen
Uwe B Schirmer,1 Tilman Steinert,1,2 Erich Flammer,1,2 Raoul Borbé1,2
1Centre for Psychiatry South-Wuerttemberg, Ravensburg, Germany; 2Ulm University, Department Psychiatry I, Ravensburg, Germany
Background: The long-term course of schizophrenia is often characterized by relapses, induced by poor medication adherence. Early nonadherence after discharge is frequent.
Objective: To evaluate a skills-based inpatient training program for medication intake.
Methods: We developed a manual-based inpatient medication training program to be carried out by nurses and focusing on practical skills enabling autonomous intake of medication. Medication adherence was measured by three different methods: pill count, determination of serum levels, and self-assessment by the patient. The raters were blinded.
Results: Four weeks after discharge, 98% of the patients in the intervention group (N=52) were rated as adherent by pill count versus 76% in the control group (N=50; P<0.01). By measurement of serum level, 88.5% versus 70% were adherent (P<0.05).
Conclusion: The inpatient medication training program carried out by nurses seems to be an effective intervention for enhancing medication adherence after hospital discharge.
Keywords: adherence, psychopharmacotherapy, schizophrenia
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]